Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
June 2, 2026
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
May 26, 2026
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 25, 2026
Cue Biopharma Announces $30 Million Private Placement
May 24, 2026
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
May 24, 2026
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
May 24, 2026
Cue Biopharma Announces 1-for-30 Reverse Stock Split
May 23, 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
May 22, 2026
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
May 21, 2026
1
2
Next Page
→